Valhi (VHI) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
10 Mar, 2026Executive summary
Reported a net loss attributable to stockholders of $53.2 million ($1.86/share) in Q4 2025, compared to net income of $22.8 million ($0.80/share) in Q4 2024.
Full year 2025 net loss was $57.6 million ($2.02/share), versus net income of $108.0 million ($3.79/share) in 2024.
Losses primarily driven by lower operating results in the Chemicals Segment and significant non-cash deferred tax expenses.
Financial highlights
Chemicals Segment net sales in Q4 2025 were $418.3 million, down 1% year-over-year; full year 2025 net sales were $1.86 billion, also down 1%.
Operating loss for Chemicals Segment in Q4 2025 was $60.1 million, compared to operating income of $32.6 million in Q4 2024.
Component Products Segment net sales in Q4 2025 were $37.7 million (down slightly), but full year sales rose to $158.3 million from $145.9 million.
Real Estate Management and Development Segment net sales in Q4 2025 were $38.5 million (up from $19.4 million); full year sales declined to $59.3 million from $71.8 million.
Interest expense increased $1.9 million in Q4 and $7.2 million for the year due to higher debt balances and rates.
Segment performance
Chemicals Segment faced lower TiO2 selling prices (down 8% in Q4 and 4% for the year), higher unabsorbed fixed production costs, and workforce reduction costs of $10.3 million in Q4.
Component Products Segment saw improved operating income in both Q4 ($5.6 million vs $4.9 million) and full year ($22.6 million vs $17.0 million), driven by higher sales and improved gross margins.
Real Estate Management and Development Segment benefited from higher Q4 land sales but saw lower full year revenue due to slower development activity.
Latest events from Valhi
- Dixie Rice's majority stake ensures approval of all board and compensation proposals.VHI
Proxy Filing2 Dec 2025 - Annual meeting to elect seven directors and hold a say-on-pay vote, with online voting available.VHI
Proxy Filing2 Dec 2025 - Q3 2025 net loss of $22.2M driven by Chemicals segment decline and higher tax expense.VHI
Q3 20256 Nov 2025 - Net income dropped sharply as Chemicals weakened and interest expense increased.VHI
Q2 20257 Aug 2025 - Q3 2024 net income surged to $57.5M on Chemicals strength and LPC acquisition gains.VHI
Q3 202413 Jun 2025 - Q2 profit surged to $19.9M as Chemicals volumes rose and costs fell, despite higher interest.VHI
Q2 202413 Jun 2025 - Q1 net income surged on Chemicals growth and LPC acquisition, with a strong 2025 outlook.VHI
Q1 20256 Jun 2025 - Valhi's 2024 profit surge was fueled by Chemicals Segment strength and strategic acquisitions.VHI
Q4 20245 Jun 2025